Administration of Antiinfectives in Minimum Volume and Infusion Times

Abstract

Get full access to this article

View all access options for this article.

References

Maki

Goldman

Rhame

. Infection control in intravenous therapy. Ann Intern Med 1973; 79: 867–87.

Maddox

John

Brown

Smith

. Effect of inline filtration on postinfusion phlebitis. Clin Pharm 1983; 2: 58–61.

Turco

Davis

. Clinical significance of particulate matter: A review of the literature. Hosp Pharm 1973; 8: 137–40.

Turco

Davis

. Preventing the injection of glass particles with furosemide solution. Hosp Pharm 1972; 7: 423–4.

Rapp

. Hospital intravenous drug administration in the era of prospective payment. Drug Intell Clin Pharm 1985; 19: 146–8.

Reilly

Steed

Ritter

. Indwelling venous access catheters in patients with acute leukemia. Cancer 1984; 53: 219–23.

Reed

. Prolonged venous access for chemotherapy by means of the Hickman catheter. Cancer 1983; 52: 185–92.

Rosenberry

Bryan

John

C Angell

. Acyclovir: Evaluation of a new antiviral agent. Clin Pharm 1982; 1: 399–406.

Hopefl

. The clinical use of intravenous acyclovir. Drug Intell Clin Pharm 1983; 17: 623–8.

10.

Package insert. Amdinocillin. Hoffman-La Roche, Nutley, NJ, 1985.

11.

Kastrup

, ed. Facts and comparisons. St. Louis: JB Lippincott Co., 1984.

12.

Product monograph. Ceforanide. Bristol Laboratories, Syracuse, NY, 1984.

13.

Fields

Bates

Abernathy

. Effect of rapid intravenous infusion on serum concentrations of amphotericin B. Appl Microbiol 1971; 22: 615–7.

14.

Utz

. Amphotericin B toxicity: General side effects. Ann Intern Med 1964; 61: 340–3.

15.

Product monograph. Cefonocid. Smith Kline & French Laboratories, Philadelphia, PA, June 1984.

16.

Package insert. Cefoperazone. Pfizer Inc., New York, 1982.

17.

Package insert. Cefotaxime. Hoescht-Rousell, Somerville, NJ, 1982.

18.

Tjandramaga

. Comparative pharmacokinetics of ceftazidime and moxalactam. Antimicrob Agents Chemother 1982; 22: 237–41.

19.

Stoeckel

. Effects of concentration dependent plasma protein binding on ceftriaxone kinetics. Clin Pharmacol Ther 1981; 29: 650–7.

20.

Package insert. Clindamycin. Upjohn Company, Kalamazoo, MI, 1983.

21.

Aucoin

Beckner

. Clindamycin induced cardiac arrest. South Med J 1982; 75: 768.

22.

Trissel

. Handbook on injectable drugs. Bethesda, MD: American Society of Hospital Pharmacists, 1983.

23.

Product monograph. Mezlocillin. Miles Laboratories, Inc., West Haven, CT, 1981.

24.

Product monograph. Miconazole. Janssen Pharmaceutica, Piscataway, NJ, 1981.

25.

Fainstein

Bodey

. Cardiorespiratory toxicity due to Miconazole. Ann Intern Med 1980; 93: 432–3.

26.

Sung

Grondahl

Levine

. Intravenous and intratheral Miconazole therapy for systemic mycoses. West J Med 1977; 126: 5–13.

27.

Package insert. Moxalactam. Lilly and Co., Indianapolis, IN, 1981.

28.

Product monograph. Piperacillin. Lederle Labs., Wayne, NJ, 1981.

29.

Deans

Lang

Smith

. Stability of trimethoprimsulfamethoxazole injection in five infusion fluids. Am J Hosp Pharm 1982; 39: 1681–4.

30.

Package insert. Tobramycin. Lilly and Co., Indianapolis, IN, 1976.

31.

Newfield

Roizen

. Hazards of rapid administration of vancomycin. Ann Intern Med 1979; 91: 581.

32.

Farber

Moellering

. Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981. Antimicrob Agents Chemother 1983; 23: 138–41.

33.

Product information. Upjohn Co., Kalamazoo, MI, 1984.